share_log

We Think China Resources Medical Holdings' (HKG:1515) Healthy Earnings Might Be Conservative

We Think China Resources Medical Holdings' (HKG:1515) Healthy Earnings Might Be Conservative

我们认为华润医疗控股(HKG:1515)的健康收益可能是保守的
Simply Wall St ·  2022/05/02 18:42

Shareholders appeared to be happy with China Resources Medical Holdings Company Limited's (HKG:1515) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers.

股东们似乎对此感到满意华润医疗控股有限公司(HKG:1515)上周公布稳健盈利报告。更深入地观察这些数字,我们发现除了整体利润数字之外,还有几个令人鼓舞的因素。

Check out our latest analysis for China Resources Medical Holdings

查看我们对华润医疗控股的最新分析

SEHK:1515 Earnings and Revenue History May 2nd 2022
联交所:2022年5月2日盈利及收入历史1515

How Do Unusual Items Influence Profit?

不寻常的项目如何影响利润?

For anyone who wants to understand China Resources Medical Holdings' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥251m due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. In the twelve months to December 2021, China Resources Medical Holdings had a big unusual items expense. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.

对于任何想要了解华润医疗控股公司超出法定数字的利润的人来说,重要的是要注意到,在过去的12个月里,由于异常项目,法定利润减少了2.51亿元人民币。看到不寻常的项目让公司损失利润从来都不是件好事,但从好的方面来看,情况可能很快就会改善。当我们分析全球绝大多数上市公司时,我们发现重大的不寻常项目往往不会重复。毕竟,这正是会计术语所暗示的。在截至2021年12月的12个月里,华润医疗控股有一大笔不寻常的项目支出。因此,我们可以推测,这些不寻常的项目使其法定利润明显低于正常情况下的水平。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让你想知道,分析师对未来盈利能力的预测是什么。幸运的是,您可以单击此处查看基于他们估计的未来盈利能力的互动图表。

An Unusual Tax Situation

不同寻常的税务情况

Having already discussed the impact of the unusual items, we should also note that China Resources Medical Holdings received a tax benefit of CN¥155m. It's always a bit noteworthy when a company is paid by the tax man, rather than paying the tax man. Of course, prima facie it's great to receive a tax benefit. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. Assuming the tax benefit is not repeated every year, we could see its profitability drop noticeably, all else being equal. While we think it's good that the company has booked a tax benefit, it does mean that there's every chance the statutory profit will come in a lot higher than it would be if the income was adjusted for one-off factors.

在讨论了这些不寻常项目的影响之后,我们还应该注意到,华润医疗控股获得了1.55亿元人民币的税收优惠。当一家公司是由税务人员支付的,而不是由税务人员支付的,这总是有一点值得注意的。当然了,表面上看能享受税收优惠真是太好了。然而,细节中的魔鬼是,这些福利只在预订的那一年影响,而且往往是一次性的。假设税收优惠不是每年重复,我们可以看到,在其他条件不变的情况下,其盈利能力显著下降。虽然我们认为该公司获得了税收优惠是件好事,但这确实意味着,法定利润很有可能会比收入经一次性因素调整后的水平高出很多。

Our Take On China Resources Medical Holdings' Profit Performance

我们对华润医疗控股公司盈利表现的看法

In the last year China Resources Medical Holdings received a tax benefit, which boosted its profit in a way that might not be much more sustainable than turning prime farmland into gas fields. Having said that, it also had a unusual item reducing its profit. Based on these factors, we think that China Resources Medical Holdings' profits are a reasonably conservative guide to its underlying profitability. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of China Resources Medical Holdings.

去年,华润医疗控股获得了一项税收优惠,以一种可能不会比将基本农田变成气田更可持续的方式提高了利润。话虽如此,它也有一个不寻常的项目减少了利润。基于这些因素,我们认为华润医疗控股的利润是衡量其潜在盈利能力的一个相当保守的指标。因此,如果你想更深入地研究这只股票,考虑它面临的任何风险是至关重要的。例如,我们发现了一个警告信号,你应该扫视一下,才能更好地了解华润医疗控股。

Our examination of China Resources Medical Holdings has focussed on certain factors that can make its earnings look better than they are. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

我们对华润医疗控股的审查集中在某些因素上,这些因素可能会让华润医疗控股的收益看起来比实际情况更好。但如果你有能力将注意力集中在细枝末节上,总会有更多的东西需要发现。一些人认为,高股本回报率是高质量企业的良好标志。所以你可能想看看这个免费拥有高股本回报率的公司的集合,或内部人士正在购买的这份股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗?保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
这篇由《华尔街日报》撰写的文章本质上是笼统的。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。简单地说,华尔街在提到的任何股票中都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发